CAR- T and also mobile gene therapies are too costly

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and innovation move can deliver cellular genetics therapies at a cost effective price to clients throughout the globe.